Antibodies for epidermal growth factor receptor 3 (HER3)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8735551
APP PUB NO 20120107306A1
SERIAL NO

13214413

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies or fragments thereof that target a conformational epitope of a HER receptor. In particular, the invention relates to antibodies or fragments thereof that target a conformational epitope of HER3 receptor and compositions and methods of use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elis, Winfried Munchen-Pasing, DE 11 88
Ettenberg, Seth Alexander Cambridge, US 11 71
Garner, Andrew Paul Cambridge, US 9 88
Haubst, Nicole Munich, DE 21 131
Kunz, Christian Munich, DE 21 192
Sprague, Elizabeth Anne Reisinger Cambridge, US 3 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 27, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00